Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

USA: Researchers have found in a new study that RSV infection, like influenza and SARS-CoV-2, was associated with a higher risk of cardiorespiratory events in the two weeks after RSV-related ...

President Trump's tariffs have been overturned, throwing the market into even more chaos in 2026.

FDA approval based on Phase 3 data demonstrating statistically significant improvements in progression‑free survival and overall survival versus standard ...

FDA approval based on Phase 3 data demonstrating statistically significant improvements in progression-free survival and overall survival versus standard of care regimens ...

Pfizer (NYSE:PFE) received its first Chinese approval for obesity drug Severwin, opening access to a major new treatment ...

Less than two weeks after Pfizer struck a deal with a Chinese drugmaker to gain commercial rights to a GLP-1 drug, the ...

Trish Saunders, 45, from Aberdeen, began using the contraceptive Depo-Provera in 1999 and continued to use it until 2016.

China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded ...

Pfizer in exchange for Pfizer releasing any claim and dismissing its appeal, according to Justia. Judge Victor Marrero said he would grant the motion if the case is remanded by the Second Circuit, and ...

FDA states collaborate lower drug prices by advancing Section 804 Importation Program and new tools to streamline state proposals for cheaper drugs.

Kyowa Kirin has decided to discontinue all clinical development of its OX40 drug after two new cancer cases emerged. | Kyowa Kirin has decided to discontinue all clinical development of its OX40 drug ...